Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 1, 2009, Pages 95-96

  Virgilio, R ^a   Corti, S ^a   Agazzi, P ^b   Santoro, D ^a   Lanfranconi, S ^a   Candelise, L ^a   Bresolin, N ^a   Comi, G P ^a   Bersano, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Civic Hospital of Lugano   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; STEROID;

AGED; ATAXIA; BONE SCINTISCANNING; CASE REPORT; CEREBELLAR ATAXIA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COORDINATION DISORDER; DYSARTHRIA; DYSMETRIA; DYSPHAGIA; FALLING; GAIT DISORDER; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PRIORITY JOURNAL; SLURRED SPEECH; SPINOCEREBELLAR DEGENERATION; WALKING AID; AUTOIMMUNE DISEASE; BLOOD; IMMUNOLOGY;

AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CEREBELLAR ATAXIA; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; STEROIDS;

EID: 58249088939     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.142745     Document Type: Letter

References (5)

1. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001: 58:225-30.
2. Vianello M, Tavolato B, Armani M, et al. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum 2003; 2:77-9.
3. Manto MU, Laute MA, Aguera M, et al. Effects of antiglutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007; 61:544-51.
4. Lauria G, Pareyson D, Pitzolu MG, et al. Excellent response to steroid treatment in anti-GAD cerebellar ataxia, Lancet Neurol 2003; 2:634-5.
5. Birand B, Cabre P, Bonnan M, et al. A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative. Rev Med Interne 2006; 27:616-19.